Moore KN - Search Results

1

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ. Moore KN, et al. Lancet Oncol. 2019 May;20(5):636-648. doi: 10.1016/S1470-2045(19)30029-4. Epub 2019 Apr 1. Lancet Oncol. 2019. PMID: 30948273 Clinical Trial.

2

Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.

Landrum LM, Gold MA, Moore KN, Myers TK, McMeekin DS, Walker JL. Landrum LM, et al. Among authors: moore kn. Gynecol Oncol. 2008 Feb;108(2):342-7. doi: 10.1016/j.ygyno.2007.10.004. Epub 2007 Nov 7. Gynecol Oncol. 2008. PMID: 17988721

3

Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.

Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, Cass IA, Rose PG, Leath CA 3rd, Rutledge T, Blankenship D, Gold MA. Moore KN, et al. Gynecol Oncol. 2007 Dec;107(3):398-403. doi: 10.1016/j.ygyno.2007.09.027. Epub 2007 Nov 7. Gynecol Oncol. 2007. PMID: 17997146

4

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Moore KN, Reid MS, Fong DN, Myers TK, Landrum LM, Moxley KM, Walker JL, McMeekin DS, Mannel RS. Moore KN, et al. Gynecol Oncol. 2008 Aug;110(2):133-9. doi: 10.1016/j.ygyno.2008.03.008. Epub 2008 May 20. Gynecol Oncol. 2008. PMID: 18495221

5

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA. Landrum LM, et al. Among authors: moore kn. Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28. Gynecol Oncol. 2009. PMID: 19041126

6

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.

Fader AN, Nagel C, Axtell AE, Zanotti KM, Kelley JL, Moore KN, Secord AA, Walsh CS, Huh WK, Gehrig PA, Gibbons H, Rose PG, Havrilesky LJ, Tuller E, Drake RD, Bottsford-Miller J, O'Malley DM; UPSC Consortium. Fader AN, et al. Among authors: moore kn. Gynecol Oncol. 2009 Mar;112(3):558-62. doi: 10.1016/j.ygyno.2008.11.016. Epub 2009 Jan 1. Gynecol Oncol. 2009. PMID: 19118888

7

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

Fader AN, Starks D, Gehrig PA, Secord AA, Frasure HE, O'Malley DM, Tuller ER, Rose PG, Havrilesky LJ, Moore KN, Huh WK, Axtell AE, Kelley JL, Zanotti KM; UPSC Consortium. Fader AN, et al. Among authors: moore kn. Gynecol Oncol. 2009 Nov;115(2):244-8. doi: 10.1016/j.ygyno.2009.07.030. Epub 2009 Aug 26. Gynecol Oncol. 2009. PMID: 19712966

8

A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study.

Tait DL, Blessing JA, Hoffman JS, Moore KN, Spirtos NM, Lachance JA, Rotmensch J, Miller DS. Tait DL, et al. Among authors: moore kn. Gynecol Oncol. 2011 Apr;121(1):118-21. doi: 10.1016/j.ygyno.2010.11.027. Epub 2010 Dec 14. Gynecol Oncol. 2011. PMID: 21159366 Clinical Trial.

9

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer.

Landrum LM, Hyde J Jr, Mannel RS, McMeekin DS, Moore KN, Walker JL. Landrum LM, et al. Among authors: moore kn. Gynecol Oncol. 2011 Sep;122(3):527-31. doi: 10.1016/j.ygyno.2011.05.022. Epub 2011 Jun 12. Gynecol Oncol. 2011. PMID: 21664657 Clinical Trial.

10

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study.

Moore KN, Sill MW, Miller DS, McCourt C, De Geest K, Rose PG, Cardenes HR, Mannel RS, Farley JH, Schilder RJ, Fracasso PM. Moore KN, et al. Gynecol Oncol. 2012 Dec;127(3):456-61. doi: 10.1016/j.ygyno.2012.08.030. Epub 2012 Sep 7. Gynecol Oncol. 2012. PMID: 22960004 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters